← Leaderboards
Jessica Eyler
Paxvax, Inc.
$697,945
Attributed
$697,945
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $235.4K · FY2022–24$250K$187.5K$125K$62.5K$0
'22
'23
'24
Funding mix
By agency
NIH$697,945 · 1
By mechanism
N02$697,945 · 1
Top collaborators
No co-investigators on record.
Most similar at Paxvax, Inc.
Same institution · by research overlap
- Marc Joseph Gurwith$21,974,740
- Jeffery Alexander$1,764,192
- Timothy Mayall$894,281
- Paul Shabram$3,434,121
- Amish Patel$149,232
Others in their field
Other Rising Stars on “Adenovirus Vector”
- Joshua D. Wythe · Baylor College Of Medicine$2,673,001
- Pamela Tinmoi Wong · University Of Michigan At Ann Arbor$1,458,527
- Ronald Lee Anderson · Rithim Biologics, Inc.$1,389,914
- Na Nora Yang · Merlin Therapeutics Inc$1,256,291
- Kara W Chew · University Of California Los Angeles$950,889
- Sang-Ho Lee · Emory University$776,166
Research focus
Adenovirus VectorClinical TrialsContractsHiv VaccineMediationProgramsProtocols DocumentationServicesVaccine Candidate
Grant awards (3)
Extended Stability Program Testing of Two Adenoviral HIV Vaccine Candidates$235,429
N02 · FY2024 · AI · contact PI
Extended Stability Program Testing of Two Adenoviral HIV Vaccine Candidates$232,637
N02 · FY2023 · AI · contact PI
Extended Stability Program Testing of Two Adenoviral HIV Vaccine Candidates$229,879
N02 · FY2022 · AI · contact PI